Ayesha Malik, MD
NPI 1447592126 · Endocrinology, Diabetes & Metabolism Physician · Davie, FL
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Ayesha Malik, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Davie, FL (NPI 1447592126).
Provider details
- NPI number
- 1447592126
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- ME124488 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
13 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
548 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 346 | $79 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 | 82 | $174 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 65 | $119 |
| Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222 | 55 | $131 |
Typical Medicare-allowed amounts for these services range $79–$174 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Pen Needle, Diabeticbrand: Nano 2nd Gen Pen Needle | 39 | 38 |
| Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar | 36 | 30 |
| Linagliptinbrand: Tradjenta | 29 | 28 |
| Glipizide | 24 | 24 |
| Metformin Hcl | 19 | 14 |
| Insulin Lisprobrand: Humalog Kwikpen U-100 | 17 | 16 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$24 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-03-20
- Last updated
- 2026-01-09
- Certified
- 2026-01-09
Frequently asked questions
- What is Ayesha Malik's NPI number?
- Ayesha Malik's National Provider Identifier (NPI) is 1447592126, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Ayesha Malik's specialty?
- Ayesha Malik is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
- Where is Ayesha Malik located?
- Ayesha Malik's practice location on file with NPPES is 5599 S University Dr Ste 305, Davie, FL 33328-5323.
- What is Ayesha Malik's phone number?
- The practice phone number listed in the NPPES registry for Ayesha Malik is (954) 880-1010.
- Does Ayesha Malik accept Medicare?
- Ayesha Malik is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Ayesha Malik's NPI active?
- Yes — Ayesha Malik's NPI (1447592126) is active in the NPPES registry as of the last update on 2026-01-09.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.